Article
Trump Preparing for Major War with Iran
A US official said that the White House is preparing for a massive, weeks-long attack on Iran. According to a US official speaking with Axios, President Donald Trump is prepared to start a war with Iran that will be much broader in scope than the 12-day conflict that Israel and the US waged against the […]
aboutLiberty Portal
Liberty Portal is your gateway for free markets and free thinking. We aggregate open-sourced content to promote and popularize important people and lessons within the liberty movement.
suggested
Jul 18, 2026 / Tyler Durden
32 Jailed Over 2018 Italian Bridge Disaster That Killed 43
32 Jailed Over 2018 Italian Bridge Disaster That Killed 43
Authored by Guy Birchall via The Epoch Times,
An Italian court sentenced 32 people to a total of more than 170 years in prison on July 16, over their role in a 2018 bridge collapse that claimed the lives of 43 people.
The collapsed Morandi Bridge in Genoa, Italy, on Aug 14, 2018. Reuters/Stefano Rellandini
The former head of Italian motorway operator Autostrade per l'Italia (ASPI), Giovanni Castellucci, received the longest sentence of 12 years in prison for his role in the disaster,...
Read more
Aug 6, 2026 / Tyler Durden
BMW Job Cuts And The Emerging German-French Industrial Strategy
BMW Job Cuts And The Emerging German-French Industrial Strategy
Submitted by Thomas Kolbe
Will German policy paralysis and French protectionism save Germany’s automakers? Unlikely, since Paris and Berlin are pursuing similar ideological goals. Everything points toward the expansion of a green state-run economy. On that, there is agreement. The concerns of private enterprise are secondary.
Given the dramatic situation, automakers would probably take even the most hopeless escape route in an attempt to escape the downward spiral. This has now also caught up with the previously remarkably resilient BMW Group: Just last...
Read more
Jun 2, 2026 / Tyler Durden
Abivax Crashes Most On Record After Cancer Cases In Trial Data Spooks Wall Street
Abivax Crashes Most On Record After Cancer Cases In Trial Data Spooks Wall Street
French biotech Abivax suffered its largest intraday decline on record after reporting new data on its lead experimental inflammatory bowel disease drug, which showed cancer cases among patients in the clinical trial. The new data certainly point to regulatory headwinds and raise the risk profile for approval.
Abivax's ABTECT maintenance data showed strong efficacy readout, with both once-daily obefazimod doses meeting the primary endpoint at week 44. Clinical remission rates were 50.8% for the 25 mg dose...
Read more




